These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30125602)

  • 1. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
    Barve A; Casson L; Krem M; Wunderlich M; Mulloy JC; Beverly LJ
    Exp Hematol; 2018 Nov; 67():18-31. PubMed ID: 30125602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved multilineage human hematopoietic reconstitution and function in NSGS mice.
    Wunderlich M; Chou FS; Sexton C; Presicce P; Chougnet CA; Aliberti J; Mulloy JC
    PLoS One; 2018; 13(12):e0209034. PubMed ID: 30540841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
    Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
    Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved chemotherapy modeling with RAG-based immune deficient mice.
    Wunderlich M; Manning N; Sexton C; Sabulski A; Byerly L; O'Brien E; Perentesis JP; Mizukawa B; Mulloy JC
    PLoS One; 2019; 14(11):e0225532. PubMed ID: 31747424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved B cell development in humanized NOD
    Jangalwe S; Shultz LD; Mathew A; Brehm MA
    Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Generation of a new strain of NOD/SCID/IL2Rγ
    Liu YC; Chen Q; Yang XL; Tang QS; Yao KT; Xu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):639-646. PubMed ID: 29997084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of macrophage activation syndrome in humanized NSGS mice.
    Tarrant JC; Binder ZA; Bugatti M; Vermi W; van den Oord J; Ranieri B; Assenmacher CA; Hoepp N; O'Rourke DM; Shan X; Danet-Desnoyers G; Radaelli E
    Res Vet Sci; 2021 Jan; 134():137-146. PubMed ID: 33383491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
    Bergstrom D; Leyton JV; Zereshkian A; Chan C; Cai Z; Reilly RM
    Nucl Med Biol; 2016 Oct; 43(10):635-41. PubMed ID: 27497632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia.
    Hu S; Niu H; Inaba H; Orwick S; Rose C; Panetta JC; Yang S; Pounds S; Fan Y; Calabrese C; Rehg JE; Campana D; Rubnitz JE; Baker SD
    J Natl Cancer Inst; 2011 Jun; 103(11):893-905. PubMed ID: 21487100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
    Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
    Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.
    Coughlan AM; Harmon C; Whelan S; O'Brien EC; O'Reilly VP; Crotty P; Kelly P; Ryan M; Hickey FB; O'Farrelly C; Little MA
    Stem Cells Dev; 2016 Apr; 25(7):530-41. PubMed ID: 26879149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
    McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA
    Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Teratocarcinomas and Teratomas in Severely Immunodeficient NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/Szj (NSG) Mice.
    Lim CY; Solter D; Knowles BB; Damjanov I
    Stem Cells Dev; 2015 Jul; 24(13):1515-20. PubMed ID: 25897827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells.
    Hasgur S; Aryee KE; Shultz LD; Greiner DL; Brehm MA
    Methods Mol Biol; 2016; 1438():67-78. PubMed ID: 27150084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
    Verma B; Wesa A
    Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
    Feuring-Buske M; Frankel A; Gerhard B; Hogge D
    Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes.
    Bock TA; Orlic D; Dunbar CE; Broxmeyer HE; Bodine DM
    J Exp Med; 1995 Dec; 182(6):2037-43. PubMed ID: 7500049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.